BENKOWITZ MICHAEL

PrivateCIK: 1673232
Location

SILVER SPRING, MD

BENKOWITZ MICHAEL (PRESIDENT AND COO) sold 14.44K shares of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $6.82M. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderBENKOWITZ MICHAELCIK 1673232
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Officer· PRESIDENT AND COO
Since Mar 2023
-14.44K
Net shares
Net seller
$6.82M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
14.44K acquired · 28.88K disposed
Non-Derivative Transactions4

Common Stock

Indirect
M · Option Exercise

Shares

+9.38K

Price / share

$117.76

Trade value

$1.10M

% of position

New position
2/23/2026
0.009.38K

Common Stock

Indirect
S · Sale

Shares

9.38K

Price / share

$472.13

Trade value

$4.43M

% of position

New position
2/23/2026
9.38K0.00

Common Stock

Indirect
M · Option Exercise

Shares

+5.07K

Price / share

$146.03

Trade value

$739.64K

% of position

New position
2/23/2026
0.005.07K

Common Stock

Indirect
S · Sale

Shares

5.07K

Price / share

$472.13

Trade value

$2.39M

% of position

New position
2/23/2026
5.07K0.00
Total

Net shares

+0.00

Net value

-$4.97M

Derivative Transactions2

Common Stock

Indirect
M · Option Exercise
Converts to

Common Stock

9.38K shares

Shares

9.38K

Strike price

117.76

Held after

0.00

Exercisable

2/23/2026

Common Stock

Indirect
M · Option Exercise
Converts to

Common Stock

5.07K shares

Shares

5.07K

Strike price

146.03

Held after

0.00

Exercisable

2/23/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Direct
Shares owned2.65K
Total
2.65K direct2.65K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
BENKOWITZ MICHAEL — Insider Transaction (Form 4) Filed Feb 24, 2026 | Finecho